Breaking News

Enesi Gets Innovate UK Funding for Aseptic Mfg.

Enables scalable aseptic manufacturing of ImplaVax-enabled solid dose viral vector vaccines

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Enesi Pharma, a pharmaceutical company developing injectable solid dose drug-device vaccine products, has secured funding from Innovate UK under the Biomedical Catalyst 2019 Round 1: Early and Late Stage Awards Initiative. The award of £870,419 will co-fund a new £1.24 million project to develop a scalable aseptic manufacturing process for live or live-attenuated viral vectors for use with Enesi’s ImplaVax needle-free solid dose technology.   “This substantial grant from Innovate UK ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters